Literature DB >> 17275650

Clostridium cadaveris septic arthritis after total hip arthroplasty in a metastatic breast cancer patient.

Saam Morshed1, Farbod Malek, Robert M Silverstein, Richard J O'Donnell.   

Abstract

We report the first known case of septic arthritis in the setting of total hip arthroplasty caused by Clostridium cadaveris, a gas-forming anaerobic enteric organism usually considered a non-pathogen. This case occurred in a patient treated with total hip arthroplasty for metastatic breast cancer involving the acetabulum. The patient was managed successfully with debridement, prosthetic retention, and chronic antibiotic suppression. We propose this mode of care as a successful alternative for some patients with prosthetic joint infection and prohibitive comorbid conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17275650     DOI: 10.1016/j.arth.2006.02.158

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  4 in total

1.  Aseptic hip pneumarthrosis following modular total hip arthroplasty: a potential mimic of hip infection.

Authors:  Yoav Morag; Corrie M Yablon; Alexander E Weber; Catherine Brandon; David J Blaha
Journal:  Emerg Radiol       Date:  2014-12-10

Review 2.  Salvage Procedures for Management of Prosthetic Joint Infection After Hip and Knee Replacements.

Authors:  Samer S S Mahmoud; Mohamed Sukeik; Sulaiman Alazzawi; Mohammed Shaath; Omar Sabri
Journal:  Open Orthop J       Date:  2016-11-30

3.  Clostridium cadaveris Osteomyelitis: an Unusual Pathogen which Highlights the Importance of Deep Tissue Sampling in Chronic Osteomyelitis.

Authors:  Ruth Alexandra Corrigan; Jose Lomas-Cabeza; David Stubbs; Martin McNally
Journal:  J Bone Jt Infect       Date:  2020-03-30

4.  First Report of Bacteremia Caused by Clostridium cadaveris in China.

Authors:  Yuanhong Xu; Yajing Liu; Xiangyun Li; Xiujie Wu
Journal:  Infect Drug Resist       Date:  2021-12-17       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.